SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001193125-23-192743
Filing Date
2023-07-25
Accepted
2023-07-25 07:11:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 14D9/A d468173dsc14d9a.htm SC 14D9/A 20528
  Complete submission text file 0001193125-23-192743.txt   22591
Mailing Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Filed by) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1230
Type: SC 14D9/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Subject) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1230
Type: SC 14D9/A | Act: 34 | File No.: 005-92879 | Film No.: 231106446
SIC: 2834 Pharmaceutical Preparations